Sierra-Paredes Germán, Sierra-Marcuño Germán
Neuroscience Division, Department of Biochemistry and Molecular Biology, School of Medicine, University of Santiago, San Francisco 1, 15782 Santiago de Compostela, Spain.
CNS Neurol Disord Drug Targets. 2007 Aug;6(4):288-300. doi: 10.2174/187152707781387251.
Epilepsy is a neurological disorder in which normal brain function is disrupted as a consequence of intensive and synchronous burst activity from neuron assemblies. Epilepsies result from long-lasting plastic changes in the brain affecting neurotransmitter release, the properties of receptors and channels, synaptic reorganization and astrocyte activity. There is considerable evidence for alterations in glutamatergic and GABAergic synaptic transmission in the origin of the paroxysmal depolarization shifts that initiate epileptic activity. However, recent studies on non-synaptic transmission, receptor mobility and glia-neuron signaling pathways suggest that extrasynaptic GABA and glutamate receptors may play an important role in seizure initiation, maintenance and arrest. Extracellular aminoacids such as glutamate, aspartate, glycine and GABA seem to communicate neurons and glial cells acting primarily on extrasynaptic receptors. Synaptic and extrasynaptic glutamate and GABA receptors have been show to play different roles in neuronal excitability. NMDA and GABAA receptors expressed in a single neuron can be differentially regulated based on subcellular localization, and it has been proposed that distinct regulation of synaptic versus extrasynaptic receptors provides a mechanism for receptor adaptation in response to a variety of stimuli. Furthermore, glutamate and GABA receptors are highly mobile, and the number and composition of extrasynaptic receptors can be modulated by several factors. This review addresses recent advances in our understanding of the role of extrasynaptic receptors in epilepsy, suggesting that extrasynaptic receptors and their mechanisms of regulation are expected to be important pharmacological targets.
癫痫是一种神经系统疾病,其中正常的脑功能因神经元集合的强烈同步爆发活动而受到干扰。癫痫是由大脑中持久的可塑性变化引起的,这些变化影响神经递质的释放、受体和通道的特性、突触重组以及星形胶质细胞的活动。有大量证据表明,在引发癫痫活动的阵发性去极化移位的起源中,谷氨酸能和γ-氨基丁酸能突触传递发生了改变。然而,最近关于非突触传递、受体移动性和胶质细胞-神经元信号通路的研究表明,突触外γ-氨基丁酸和谷氨酸受体可能在癫痫发作的起始、维持和终止中发挥重要作用。细胞外氨基酸,如谷氨酸、天冬氨酸、甘氨酸和γ-氨基丁酸,似乎主要通过作用于突触外受体来实现神经元和胶质细胞之间的通讯。突触和突触外的谷氨酸和γ-氨基丁酸受体在神经元兴奋性中发挥着不同的作用。在单个神经元中表达的N-甲基-D-天冬氨酸(NMDA)受体和γ-氨基丁酸A型(GABAA)受体可根据亚细胞定位进行差异调节,有人提出,突触受体与突触外受体的不同调节为受体适应各种刺激提供了一种机制。此外,谷氨酸和γ-氨基丁酸受体具有高度的移动性,突触外受体的数量和组成可受多种因素调节。本综述阐述了我们对突触外受体在癫痫中作用的理解的最新进展,表明突触外受体及其调节机制有望成为重要的药理学靶点。